−29JPY
−846.53 MJPY
190.13 MJPY
30.87 M
About CELLSEED INC
Sector
Headquarters
Tokyo
Employees (FY)
35
Website
Founded
2001
ISIN
JP3423530009
FIGI
BBG000QB3PT6
CellSeed Inc. develops regenerative medicine products. It operates through the Cell Sheet Regenerative Medicine and Intelligent Regenerative Medicine Support segments. The Cell Sheet Regenerative Medicine segment provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis. The Regenerative Medicine Support segment conducts research and development, manufacturing, and sales of temperature-responsive cell culture equipment. The company was founded by Yukio Hasegawa on May 9, 2001 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 7776 is 210 JPY — it has decreased by 2.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CELLSEED INC stocks are traded under the ticker 7776.
CELLSEED INC is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track CELLSEED INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 7776 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLSEED INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 35.00 employees. See our rating of the largest employees — is CELLSEED INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLSEED INC EBITDA is −689.84 M JPY, and current EBITDA margin is −292.24%. See more stats in CELLSEED INC financial statements.